MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.biopha.2023.114675

Медицинская библиотека · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation.

Shen Fang, Wu Celiang, Zhong Xiaomei, Ma En, Peng Jun, Zhu Weidong, Wo Da, Ren Dan-Ni

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Myocardial infarction (MI) is the leading cause of deaths worldwide, triggering widespread and irreversible damage to the heart. Currently, there are no drugs that can reverse ischemic damage to the myocardium and hence, finding novel therapeutic agents that can limit the extent of myocardial damage following MI is crucial. Liensinine (LSN) is a naturally derived bisbenzylisoquinoline alkaloid that is known to exhibit numerous antioxidative and cardiovascular beneficial effects. However, the role of LSN in MI-induced injury and its underlying mechanisms remain unexplored.

PURPOSE: Our study aims to evaluate the cardioprotective effects of LSN following MI and its underlying molecular mechanisms.

METHODS

We constructed murine models of MI in order to examine the potential cardioprotective effects and mechanisms of LSN in protecting against myocardial ischemic damage both in vivo and in vitro.

RESULTS

Administration with LSN strongly protected against cardiac injuries following MI by decreasing the extent of ischemic damage and improving cardiac function. Additionally, LSN was found to be a potent inhibitor of Wnt/β‑catenin signaling pathway. Hence, the beneficial effects of LSN in preventing oxidative and DNA damage following ischemia was due to its ability to inhibit aberrant activation of Wnt/β‑catenin signaling.

CONCLUSIONS

Our findings reveal for the first time a novel cardioprotective role of LSN during myocardial infarction and most notably, its ability to protect cardiomyocytes against oxidative stress-induced damage via inhibiting Wnt/β-catenin signaling. Our study therefore suggests new therapeutic potential of LSN or plants that contain the natural alkaloid LSN in ischemic heart diseases.

Для цитирования: Shen Fang, Wu Celiang, Zhong Xiaomei, Ma En, Peng Jun, Zhu Weidong, Wo Da, Ren Dan-Ni. Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023. DOI: 10.1016/j.biopha.2023.114675.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.